Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti infective Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel pleuromutilin derivatives with thiazole-pyridine side chains offer superior antibacterial activity against resistant strains, featuring a scalable three-step synthesis.
Patent CN111471017A reveals a green organocatalytic route for Ornidazole and Secnidazole, offering high purity, reduced waste, and cost-effective manufacturing for global supply chains.
Patent CN1481365A reveals a novel organosilicon cyclization route for quinolones. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Discover the novel neutral alumina chromatography method for Ornidazole purification. Achieve >99.6% purity with reduced toxic residues for pharmaceutical manufacturing.
Patent CN101792433B reveals a greener, high-yield synthesis route for this anti-infective intermediate, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Advanced synthesis of N-3-isoxazole carbamic acid tert-butyl ester via patent CN109369553B. Delivers high purity, scalable production, and cost-effective supply chain solutions.
Advanced esterification process for Metronidazole Benzoate yielding 91.5-95%. Offers significant cost reduction in pharma manufacturing through efficient solvent recycling.
Novel one-pot synthesis of Nifuratel avoiding high vacuum distillation. High purity >99.8%. Cost-effective industrial scale-up for pharma intermediates.